On May 29, 2019 Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA (Press release, Infinity Pharmaceuticals, MAY 29, 2019, View Source [SID1234536650]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Adelene Perkins, Infinity Pharmaceutical’s Chief Executive Officer, will provide a company overview on Tuesday, June 4, 2019, at 2:45 p.m. ET. A live webcast of the presentation will be available on the Investors/Media section of Infinity’s website at www.infi.com, and will be available for 30 days following the event.
Dr. Samuel Agresta, Infinity Pharmaceutical’s Chief Medical Officer, will participate in a panel, "What Was Hot at ASCO (Free ASCO Whitepaper) 2019? Highlights from the World’s Biggest Oncology Meeting," discussing key data from the 2019 ASCO (Free ASCO Whitepaper) Annual Meeting and providing insights on future trends in oncology treatments. Panelists include:
Ted Tenthoff, Senior Research Analyst, Piper Jaffray, Moderator
Roy Baynes, BCH, MB, M.D., Med, Ph.D., SVP, and Head Global Clinical Development, Chief Medical Officer, Merck Research Laboratories
Howard "Skip" Burris III, M.D., FACP, FASCO, President, ASCO (Free ASCO Whitepaper)
Patricia Keegan, M.D., Director, Division of Oncology Products 2, Center for Drug Evaluation and Research (CDER), FDA
The panel will take place on Wednesday, June 5, 2019, at 11:00 a.m. ET.